NASDAQ: CSBR
Champions Oncology Inc Stock Ownership - Who owns Champions Oncology?

Insider buying vs selling

Have Champions Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joel AckermanDirector2024-10-3116,667$5.43
$90.50kBuy
Joel AckermanDirector2024-10-3188,470$2.10
$185.79kBuy

1 of 1

CSBR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CSBR insiders and whales buy or sell their stock.

CSBR Shareholders

What type of owners hold Champions Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Michael Maurice Brown169.54%23,442,589$171.37MInsider
Harry R. Weller135.61%18,750,000$137.06MInsider
Krishna Kittu Kolluri135.61%18,750,000$137.06MInsider
Patrick J. Kerins135.61%18,750,000$137.06MInsider
David M. Mott135.61%18,750,000$137.06MInsider
Anthony A. Florence Jr.135.61%18,750,000$137.06MInsider
Scott D. Sandell135.61%18,750,000$137.06MInsider
Ryan D. Drant135.61%18,750,000$137.06MInsider
M. James Barrett135.61%18,750,000$137.06MInsider
Peter J. Barris135.61%18,750,000$137.06MInsider

1 of 3

CSBR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CSBR1.94%98.06%Net Buying
GNLX14.08%6.43%Net Selling
TVRD3.49%96.51%Net SellingNet Selling
ATOS23.17%14.77%Net BuyingNet Buying
COYA26.57%12.80%Net Buying

Champions Oncology Stock Ownership FAQ

Who owns Champions Oncology?

Champions Oncology (NASDAQ: CSBR) is owned by 41.36% institutional shareholders, 2,093.50% Champions Oncology insiders, and 0.00% retail investors. Michael Maurice Brown is the largest individual Champions Oncology shareholder, owning 23.44M shares representing 169.54% of the company. Michael Maurice Brown's Champions Oncology shares are currently valued at $176.29M.

If you're new to stock investing, here's how to buy Champions Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.